You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

LATANOPROST Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Latanoprost

A generic version of LATANOPROST was approved as latanoprost by AMRING PHARMS on March 22nd, 2011.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for LATANOPROST?
  • What are the global sales for LATANOPROST?
  • What is Average Wholesale Price for LATANOPROST?
Drug patent expirations by year for LATANOPROST
Drug Prices for LATANOPROST

See drug prices for LATANOPROST

Drug Sales Revenue Trends for LATANOPROST

See drug sales revenues for LATANOPROST

Recent Clinical Trials for LATANOPROST

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
DataPharm Australia, CMAX Clinical Research, Agilex AustraliaPhase 1
Aneira Pharma, Inc.Phase 1
Peregrine OphthalmicPhase 1

See all LATANOPROST clinical trials

Pharmacology for LATANOPROST
Anatomical Therapeutic Chemical (ATC) Classes for LATANOPROST

US Patents and Regulatory Information for LATANOPROST

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amring Pharms LATANOPROST latanoprost SOLUTION/DROPS;OPHTHALMIC 200925-001 Mar 22, 2011 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ryan Labs LATANOPROST latanoprost SOLUTION/DROPS;OPHTHALMIC 202077-001 Feb 11, 2013 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Epic Pharma Llc LATANOPROST latanoprost SOLUTION/DROPS;OPHTHALMIC 090887-001 Jul 19, 2011 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz LATANOPROST latanoprost SOLUTION/DROPS;OPHTHALMIC 091449-001 Mar 22, 2011 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apotex Inc LATANOPROST latanoprost SOLUTION/DROPS;OPHTHALMIC 077697-001 Mar 22, 2011 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.